Philips Trilogy EV300 Recall - Tidal Volume Discrepancy Risk
Summary
The FDA issued a Class I recall (Z-1616-2026) for Philips Respironics Trilogy EV300 ventilators running Software Version 1.05.15.00 due to tidal volume discrepancies when non-pneumatic nebulizers are used. The recall affects devices distributed both domestically and internationally. Philips is notifying customers of the safety issue and providing guidance on mitigating the risk.
What changed
Philips Respironics initiated a Class I recall for Trilogy EV300 continuous home-use ventilators (Software Version 1.05.15.00) after discovering that using non-pneumatic nebulizers with these devices may result in a discrepancy between the set tidal volume and the tidal volume actually delivered to the patient. Class I is the most serious recall classification, indicating reasonable probability of serious adverse health consequences or death. The recall affects devices distributed worldwide, including throughout the US.
Healthcare providers and durable medical equipment suppliers should immediately identify any Trilogy EV300 devices in use or inventory, notify patients and caregivers of the tidal volume discrepancy risk when non-pneumatic nebulizers are co-used, and contact Philips Respironics for replacement options or repair instructions. Patients should not stop using their ventilator without consulting their healthcare provider. The recall is ongoing, and Philips is expected to provide further instructions through their customer notification process.
What to do next
- Identify all Trilogy EV300 ventilators (Software Version 1.05.15.00) in clinical or home use
- Notify patients and caregivers of tidal volume discrepancy risk when non-pneumatic nebulizers are co-used with Trilogy EV300 devices
- Contact Philips Respironics for repair/replacement options and follow recall-specific guidance
Source document (simplified)
Philips Respironics, Inc.
Device Recalls (Class I)
← All Device Recalls (Class I) Class I Z-1616-2026 · 20260401 · Ongoing
Product
Philips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use ventilator device.
Reason for Recall
Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Distribution
Worldwide distribution: US (Nationwide) and OUS (Foreign) to countries of: Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh, Belgi...
Source: openFDA Enforcement API
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class I publishes new changes.